Daisy Lin

Daisy Lin, PhD has a diverse work experience in the field of oncology research and clinical trials. Daisy currently holds the position of Director, Global Oncology R&D at Daiichi Sankyo, Inc. Prior to this, they worked at Weill Cornell Medicine as a Clinical Trials Program Manager/Clinical Trial Development Lead for the Children's Brain Tumor Project, where they were responsible for designing and executing clinical trial protocols and collaborating with various stakeholders. Daisy also worked at SUNY Downstate Medical Center as a Principal Research Scientist/Clinical Research Lead, focusing on investigating the effects of drug exposure on brain disorders and leading clinical research projects in epilepsy. Earlier in their career, they were a Postdoctoral Research Fellow at Columbia University Irving Medical Center.

Daisy Lin, PhD, earned their Doctor of Philosophy (PhD) degree in Cell/Cellular and Molecular Biology from Downstate Health Sciences University. Daisy completed their studies between 2002 and 2008.